Preparation of a size selective nanocomposite through temperature assisted co-assembly of gelatin and pluronic F127 for passive targeting of doxorubicin
The preparation of a water dispersible and pH responsive gelatin-F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that physical properties (size and surface charge) of the gelatin-F127 nanoparticle can be tuned by varying the F127 to gelatin weight ratio. The...
Saved in:
Published in | Biomaterials science Vol. 8; no. 15; pp. 4251 - 4265 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
07.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The preparation of a water dispersible and pH responsive gelatin-F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that physical properties (size and surface charge) of the gelatin-F127 nanoparticle can be tuned by varying the F127 to gelatin weight ratio. The heating (60 °C) of a saline solution (pH 7.4) containing 0.5% (w/v) of gelatin and 20% (w/w of gelatin) of F127 followed by gradual cooling at room temperature yielded nanoparticles of desired size (160 ± 40 nm), viscosity (1.36 ± cP) and surface charge (−6.47 ± 0.7 mV). The drug delivery application of nanocarriers was investigated using doxorubicin hydrochloride (Dox) as a model drug. These nanocarriers showed high encapsulation efficiency of Dox (85%), a sustained release profile, and substantial cellular internalization. Additionally, Dox loaded nanocarriers (G-Dox) exhibited prolonged residence in blood as evidenced by their longer circulation time as compared to plain Dox. Moreover, G-Dox exhibited a higher availability of the drug in plasma as compared to nonspecific organs such as the heart, liver and kidneys, highlighting its significance in reducing drug associated side effects. Finally, the enhanced toxicity of G-Dox to a WEHI-164 (fibrosarcoma) tumor model as compared to that of plain Dox under an identical dosage of 6 mg per kg body weight (IP) confirmed its potential for chemotherapy application.
The study demonstrates the importance of the weight ratio of F127 and gelatin in forming size selective nanoconjugate through a thermal relaxation approach and its potential as an efficient drug delivery system of doxorubicin with reduced side effects. |
---|---|
AbstractList | The preparation of a water dispersible and pH responsive gelatin-F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that physical properties (size and surface charge) of the gelatin-F127 nanoparticle can be tuned by varying the F127 to gelatin weight ratio. The heating (60 °C) of a saline solution (pH 7.4) containing 0.5% (w/v) of gelatin and 20% (w/w of gelatin) of F127 followed by gradual cooling at room temperature yielded nanoparticles of desired size (160 ± 40 nm), viscosity (1.36 ± cP) and surface charge (-6.47 ± 0.7 mV). The drug delivery application of nanocarriers was investigated using doxorubicin hydrochloride (Dox) as a model drug. These nanocarriers showed high encapsulation efficiency of Dox (85%), a sustained release profile, and substantial cellular internalization. Additionally, Dox loaded nanocarriers (G-Dox) exhibited prolonged residence in blood as evidenced by their longer circulation time as compared to plain Dox. Moreover, G-Dox exhibited a higher availability of the drug in plasma as compared to nonspecific organs such as the heart, liver and kidneys, highlighting its significance in reducing drug associated side effects. Finally, the enhanced toxicity of G-Dox to a WEHI-164 (fibrosarcoma) tumor model as compared to that of plain Dox under an identical dosage of 6 mg per kg body weight (IP) confirmed its potential for chemotherapy application. The preparation of a water dispersible and pH responsive gelatin–F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that physical properties (size and surface charge) of the gelatin–F127 nanoparticle can be tuned by varying the F127 to gelatin weight ratio. The heating (60 °C) of a saline solution (pH 7.4) containing 0.5% (w/v) of gelatin and 20% (w/w of gelatin) of F127 followed by gradual cooling at room temperature yielded nanoparticles of desired size (160 ± 40 nm), viscosity (1.36 ± cP) and surface charge (−6.47 ± 0.7 mV). The drug delivery application of nanocarriers was investigated using doxorubicin hydrochloride (Dox) as a model drug. These nanocarriers showed high encapsulation efficiency of Dox (85%), a sustained release profile, and substantial cellular internalization. Additionally, Dox loaded nanocarriers (G-Dox) exhibited prolonged residence in blood as evidenced by their longer circulation time as compared to plain Dox. Moreover, G-Dox exhibited a higher availability of the drug in plasma as compared to nonspecific organs such as the heart, liver and kidneys, highlighting its significance in reducing drug associated side effects. Finally, the enhanced toxicity of G-Dox to a WEHI-164 (fibrosarcoma) tumor model as compared to that of plain Dox under an identical dosage of 6 mg per kg body weight (IP) confirmed its potential for chemotherapy application. The preparation of a water dispersible and pH responsive gelatin-F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that physical properties (size and surface charge) of the gelatin-F127 nanoparticle can be tuned by varying the F127 to gelatin weight ratio. The heating (60 °C) of a saline solution (pH 7.4) containing 0.5% (w/v) of gelatin and 20% (w/w of gelatin) of F127 followed by gradual cooling at room temperature yielded nanoparticles of desired size (160 ± 40 nm), viscosity (1.36 ± cP) and surface charge (−6.47 ± 0.7 mV). The drug delivery application of nanocarriers was investigated using doxorubicin hydrochloride (Dox) as a model drug. These nanocarriers showed high encapsulation efficiency of Dox (85%), a sustained release profile, and substantial cellular internalization. Additionally, Dox loaded nanocarriers (G-Dox) exhibited prolonged residence in blood as evidenced by their longer circulation time as compared to plain Dox. Moreover, G-Dox exhibited a higher availability of the drug in plasma as compared to nonspecific organs such as the heart, liver and kidneys, highlighting its significance in reducing drug associated side effects. Finally, the enhanced toxicity of G-Dox to a WEHI-164 (fibrosarcoma) tumor model as compared to that of plain Dox under an identical dosage of 6 mg per kg body weight (IP) confirmed its potential for chemotherapy application. The study demonstrates the importance of the weight ratio of F127 and gelatin in forming size selective nanoconjugate through a thermal relaxation approach and its potential as an efficient drug delivery system of doxorubicin with reduced side effects. |
Author | Kunwar, Amit Singh, Beena Gobind Das, Ram Pada |
AuthorAffiliation | Radiation & Photochemistry Division Bhabha Atomic Research Centre Homi Bhabha National Institute |
AuthorAffiliation_xml | – name: Bhabha Atomic Research Centre – name: Radiation & Photochemistry Division – name: Homi Bhabha National Institute |
Author_xml | – sequence: 1 givenname: Ram Pada surname: Das fullname: Das, Ram Pada – sequence: 2 givenname: Beena Gobind surname: Singh fullname: Singh, Beena Gobind – sequence: 3 givenname: Amit surname: Kunwar fullname: Kunwar, Amit |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32583820$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1TAQhS1UREvphj3IiA1CCkzsxE6WUCggimAB68g_41uXxE7tBFGehMfFl1suEgtmMyOd7xyNdO6SgxADEnK_hmc18P65BT0BSNZ-vUWOGDSyarqmP9jfHA7JSc6XUEbKHkR9hxxy1na8Y3BEfn5KOKukFh8DjY4qmv0PpBlHNIv_hjSoEE2c5pj9gnS5SHHdXNAFpxmLa01IVc4-L2ipiVW5cdLj9TZqg2OJDVQFS-dxTTF4Q89qJqmLic5bW8lfVNpgwTZbi43fY1q1Nz7cI7edGjOe3Oxj8uXs9efTt9X5xzfvTl-cV4YLvlSOcQEgpO0l450FgVC3TjQ1IOu1AGd7bRuhdGtYLaRstTHGGWGs1qzjmh-TJ7vcOcWrFfMyTD4bHEcVMK55YE0tG2hA8II-_ge9jGsK5btCMdky0cu2UE93lEkx54RumJOfVLoeahi2lQ2v4OWH35W9L_DDm8hVT2j36J-CCvBgB6Rs9urfzov-6H_6MFvHfwF5iKps |
CitedBy_id | crossref_primary_10_1016_j_ijbiomac_2022_04_134 crossref_primary_10_1016_j_jddst_2023_105281 crossref_primary_10_1016_j_ijbiomac_2023_126337 crossref_primary_10_1002_jbm_a_37287 crossref_primary_10_1016_j_biopha_2024_116330 crossref_primary_10_1039_D2SD00154C crossref_primary_10_1016_j_biotechadv_2020_107657 crossref_primary_10_1016_j_biopha_2024_116446 crossref_primary_10_2147_IJN_S443692 crossref_primary_10_1039_D3MA00825H crossref_primary_10_1016_j_ijbiomac_2022_05_192 crossref_primary_10_1039_D1TB02470A crossref_primary_10_1021_acsnano_4c01120 crossref_primary_10_1016_j_ijbiomac_2022_05_087 |
Cites_doi | 10.1504/IJNM.2009.028116 10.2174/1381612825666190830155319 10.1074/jbc.M112.376855 10.2174/092986709788803312 10.1002/mabi.201200382 10.1039/C3SM52542B 10.1016/0002-8703(81)90096-X 10.1039/b919944f 10.1016/j.matlet.2016.09.095 10.1021/acs.bioconjchem.9b00755 10.1038/nature12626 10.1016/j.colsurfb.2010.12.022 10.1016/j.jconrel.2014.04.014 10.1021/la400268p 10.1021/mp200522d 10.1016/j.jconrel.2015.04.032 10.1016/j.colsurfb.2009.09.001 10.3389/fphar.2018.00421 10.1016/j.jcis.2011.11.024 10.1517/17425247.5.5.499 10.1111/j.2042-7158.2012.01567.x 10.1063/1.464456 10.4155/tde.10.24 10.1021/jp905781g 10.1080/10611860600935701 10.1016/j.jconrel.2011.07.031 10.1016/S0168-3659(97)00247-2 10.1155/2017/1521020 10.1021/mp070058l 10.1016/j.ijpharm.2007.03.036 10.1002/jps.2600660714 10.1021/acschembio.5b00268 10.1016/S0142-9612(00)00236-2 10.1021/nn101617n 10.1016/j.jconrel.2013.09.019 10.1016/0002-8703(80)90743-7 10.1021/ma980982g 10.1007/BF00434396 10.1163/156856202320892966 10.1016/j.colsurfb.2017.07.048 10.1051/jphys:01988004902031900 10.1016/j.ijpharm.2005.10.010 10.1172/JCI118836 10.1081/CNV-120025086 10.1039/C7RA01118K 10.1021/mp8001528 10.1021/acsbiomaterials.8b01098 10.1016/j.xphs.2015.11.015 10.1016/j.drudis.2014.08.015 10.1021/ie50167a018 10.1006/phrs.2000.0769 10.1021/acs.bioconjchem.6b00437 10.1039/b921735e 10.1016/j.colsurfa.2019.01.043 10.1002/marc.200900163 10.1023/A:1016097805003 10.1021/acsami.6b07583 10.1021/bc100070g 10.1021/bm0343139 10.4172/2157-7439.1000519 10.1016/j.jconrel.2012.04.036 10.1039/C4PY00039K 10.1016/j.ejpb.2010.05.008 10.1021/nn200809t 10.1038/nprot.2006.238 10.1007/s12034-019-1745-0 10.1097/FPC.0b013e32833ffb56 10.1021/acs.bioconjchem.9b00236 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P 10.1016/j.colsurfb.2015.08.002 10.1016/0142-9612(93)90004-L 10.1021/acs.jpcb.6b00759 |
ContentType | Journal Article |
Copyright | Copyright Royal Society of Chemistry 2020 |
Copyright_xml | – notice: Copyright Royal Society of Chemistry 2020 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 |
DOI | 10.1039/d0bm00725k |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Materials Research Database Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Materials Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 2047-4849 |
EndPage | 4265 |
ExternalDocumentID | 10_1039_D0BM00725K 32583820 d0bm00725k |
Genre | Journal Article |
GroupedDBID | 0-7 0R 4.4 53G 705 AAEMU AAGNR AAIWI AANOJ ABDVN ABGFH ABRYZ ACGFS ACIWK ACLDK ADMRA ADSRN AENEX AFVBQ AGSTE AGSWI ALMA_UNASSIGNED_HOLDINGS ASKNT AUDPV BLAPV BSQNT C6K CKLOX EBS ECGLT EE0 EF- HZ H~N J3I JG O-G O9- OK1 RCNCU RPMJG RRC RSCEA -JG 0R~ AAHBH AAJAE AARTK AAWGC AAXHV ABASK ABEMK ABJNI ABPDG ABXOH AEFDR AENGV AESAV AETIL AFLYV AFOGI AGEGJ AGRSR AHGCF AKBGW ANUXI APEMP CGR CUY CVF ECM EIF GGIMP H13 HZ~ NPM RAOCF RVUXY AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 |
ID | FETCH-LOGICAL-c363t-f2360067d97238d06e015f6410e29b60fd9bd46ab5c216775bcccfc6cdbb283b3 |
ISSN | 2047-4830 |
IngestDate | Sat Aug 17 00:40:05 EDT 2024 Fri Sep 13 07:44:16 EDT 2024 Fri Aug 23 02:59:45 EDT 2024 Sat Sep 28 08:25:28 EDT 2024 Sat Jan 08 03:53:07 EST 2022 Wed Nov 11 00:27:42 EST 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c363t-f2360067d97238d06e015f6410e29b60fd9bd46ab5c216775bcccfc6cdbb283b3 |
Notes | Electronic supplementary information (ESI) available. See DOI 10.1039/d0bm00725k ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-1017-1527 0000-0002-1679-5456 |
PMID | 32583820 |
PQID | 2427526975 |
PQPubID | 2047520 |
PageCount | 15 |
ParticipantIDs | pubmed_primary_32583820 proquest_miscellaneous_2417404063 proquest_journals_2427526975 crossref_primary_10_1039_D0BM00725K rsc_primary_d0bm00725k |
PublicationCentury | 2000 |
PublicationDate | 2020-08-07 |
PublicationDateYYYYMMDD | 2020-08-07 |
PublicationDate_xml | – month: 08 year: 2020 text: 2020-08-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Cambridge |
PublicationTitle | Biomaterials science |
PublicationTitleAlternate | Biomater Sci |
PublicationYear | 2020 |
Publisher | Royal Society of Chemistry |
Publisher_xml | – name: Royal Society of Chemistry |
References | Dreis (D0BM00725K-(cit20)/*[position()=1]) 2007; 34 Santoro (D0BM00725K-(cit25)/*[position()=1]) 2014; 190 Lee (D0BM00725K-(cit43)/*[position()=1]) 2010; 6 Saad (D0BM00725K-(cit75)/*[position()=1]) 2001; 43 Meng (D0BM00725K-(cit12)/*[position()=1]) 2011; 5 Henderson (D0BM00725K-(cit7)/*[position()=1]) 1980; 99 Tatini (D0BM00725K-(cit64)/*[position()=1]) 2015; 1 Rio-Echevarria (D0BM00725K-(cit70)/*[position()=1]) 2010; 20 Kurisawa (D0BM00725K-(cit27)/*[position()=1]) 1998; 54 Jean (D0BM00725K-(cit55)/*[position()=1]) 2015; 10 Elzoghby (D0BM00725K-(cit19)/*[position()=1]) 2012; 157 Nakamura (D0BM00725K-(cit68)/*[position()=1]) 2016; 27 Wu (D0BM00725K-(cit44)/*[position()=1]) 2009; 30 Riccardi (D0BM00725K-(cit48)/*[position()=1]) 2006; 1 Roy (D0BM00725K-(cit46)/*[position()=1]) 1977; 66 Das (D0BM00725K-(cit58)/*[position()=1]) 2019; 25 Ramadoss (D0BM00725K-(cit61)/*[position()=1]) 2017; 186 Johansen (D0BM00725K-(cit50)/*[position()=1]) 1981; 5 Tan (D0BM00725K-(cit69)/*[position()=1]) 1993; 14 Pitto-Barry (D0BM00725K-(cit37)/*[position()=1]) 2014; 5 Das (D0BM00725K-(cit45)/*[position()=1]) 2017; 1 Junttila (D0BM00725K-(cit72)/*[position()=1]) 2013; 501 Akash (D0BM00725K-(cit38)/*[position()=1]) 2015; 209 Bigi (D0BM00725K-(cit62)/*[position()=1]) 2001; 22 Minotti (D0BM00725K-(cit8)/*[position()=1]) 1996; 98 Tacar (D0BM00725K-(cit3)/*[position()=1]) 2013; 65 Elzoghby (D0BM00725K-(cit22)/*[position()=1]) 2013; 172 Wang (D0BM00725K-(cit71)/*[position()=1]) 2010; 1 Aman (D0BM00725K-(cit6)/*[position()=1]) 1985; 55 Suarasan (D0BM00725K-(cit53)/*[position()=1]) 2016; 8 Elzoghby (D0BM00725K-(cit16)/*[position()=1]) 2012; 161 Mondal (D0BM00725K-(cit41)/*[position()=1]) 2016; 120 Wang (D0BM00725K-(cit56)/*[position()=1]) 2010; 1 Maeda (D0BM00725K-(cit13)/*[position()=1]) 2010; 21 Chao (D0BM00725K-(cit14)/*[position()=1]) 2003; 21 Sudesh (D0BM00725K-(cit30)/*[position()=1]) 2010; 75 Michael (D0BM00725K-(cit9)/*[position()=1]) 1981; 102 Kaminskas (D0BM00725K-(cit49)/*[position()=1]) 2012; 9 Hou (D0BM00725K-(cit36)/*[position()=1]) 2019; 30 Miele (D0BM00725K-(cit59)/*[position()=1]) 2009; 4 Verhoef (D0BM00725K-(cit34)/*[position()=1]) 2014; 19 Lefebvre (D0BM00725K-(cit76)/*[position()=1]) 1996; 13 Turecek (D0BM00725K-(cit35)/*[position()=1]) 2016; 105 Chen (D0BM00725K-(cit40)/*[position()=1]) 2013; 29 Dang (D0BM00725K-(cit65)/*[position()=1]) 2019; 42 Meng (D0BM00725K-(cit23)/*[position()=1]) 2011; 84 Das (D0BM00725K-(cit47)/*[position()=1]) 2019; 567 Thorn (D0BM00725K-(cit2)/*[position()=1]) 2011; 21 Bogue (D0BM00725K-(cit21)/*[position()=1]) 1923; 15 Khan (D0BM00725K-(cit67)/*[position()=1]) 2013; 85950 Carvalho (D0BM00725K-(cit54)/*[position()=1]) 2009; 16 Bayoumi (D0BM00725K-(cit10)/*[position()=1]) 2009; 6 Abdullah (D0BM00725K-(cit24)/*[position()=1]) 2018; 47 Cappetta (D0BM00725K-(cit5)/*[position()=1]) 2017; 2 Gou (D0BM00725K-(cit11)/*[position()=1]) 2009; 113 Zimmermann (D0BM00725K-(cit74)/*[position()=1]) 2012; 287 Caragheorgheopol (D0BM00725K-(cit39)/*[position()=1]) 1998; 31 Lee (D0BM00725K-(cit31)/*[position()=1]) 2006; 14 Kushibiki (D0BM00725K-(cit32)/*[position()=1]) 2004; 5 Ziaei (D0BM00725K-(cit60)/*[position()=1]) 2019; 30 Gou (D0BM00725K-(cit57)/*[position()=1]) 2018; 9 Manju (D0BM00725K-(cit73)/*[position()=1]) 2012; 368 Khan (D0BM00725K-(cit66)/*[position()=1]) 2013; 13 Zhao (D0BM00725K-(cit1)/*[position()=1]) 2018; 9 Ulubayram (D0BM00725K-(cit33)/*[position()=1]) 2002; 13 Wang (D0BM00725K-(cit18)/*[position()=1]) 2008; 5 Owens (D0BM00725K-(cit29)/*[position()=1]) 2006; 307 Djabourov (D0BM00725K-(cit51)/*[position()=1]) 1988; 49 Yeh (D0BM00725K-(cit63)/*[position()=1]) 2017; 7 Yang (D0BM00725K-(cit4)/*[position()=1]) 2014; 1845 Zhang (D0BM00725K-(cit42)/*[position()=1]) 2010; 4 Lu (D0BM00725K-(cit15)/*[position()=1]) 2007; 4 Pelc (D0BM00725K-(cit52)/*[position()=1]) 2014; 10 Jain (D0BM00725K-(cit17)/*[position()=1]) 2018; 4 Bohidar (D0BM00725K-(cit28)/*[position()=1]) 1993; 98 Curcio (D0BM00725K-(cit26)/*[position()=1]) 2010; 76 |
References_xml | – volume: 4 start-page: 99 year: 2009 ident: D0BM00725K-(cit59)/*[position()=1] publication-title: Int. J. Nanomed. doi: 10.1504/IJNM.2009.028116 contributor: fullname: Miele – volume: 47 start-page: 323 year: 2018 ident: D0BM00725K-(cit24)/*[position()=1] publication-title: Sains Malays. contributor: fullname: Abdullah – volume: 25 start-page: 3034 year: 2019 ident: D0BM00725K-(cit58)/*[position()=1] publication-title: Curr. Pharm. Des. doi: 10.2174/1381612825666190830155319 contributor: fullname: Das – volume: 287 start-page: 22838 year: 2012 ident: D0BM00725K-(cit74)/*[position()=1] publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.376855 contributor: fullname: Zimmermann – volume: 16 start-page: 3267 year: 2009 ident: D0BM00725K-(cit54)/*[position()=1] publication-title: Curr. Med. Chem. doi: 10.2174/092986709788803312 contributor: fullname: Carvalho – volume: 13 start-page: 455 year: 2013 ident: D0BM00725K-(cit66)/*[position()=1] publication-title: Macromol. Biosci. doi: 10.1002/mabi.201200382 contributor: fullname: Khan – volume: 10 start-page: 348 year: 2014 ident: D0BM00725K-(cit52)/*[position()=1] publication-title: Soft Matter doi: 10.1039/C3SM52542B contributor: fullname: Pelc – volume: 102 start-page: 709 year: 1981 ident: D0BM00725K-(cit9)/*[position()=1] publication-title: Am. Heart J. doi: 10.1016/0002-8703(81)90096-X contributor: fullname: Michael – volume: 6 start-page: 977 year: 2010 ident: D0BM00725K-(cit43)/*[position()=1] publication-title: Soft Matter doi: 10.1039/b919944f contributor: fullname: Lee – volume: 186 start-page: 109 year: 2017 ident: D0BM00725K-(cit61)/*[position()=1] publication-title: Mater. Lett. doi: 10.1016/j.matlet.2016.09.095 contributor: fullname: Ramadoss – volume: 30 start-page: 3098 year: 2019 ident: D0BM00725K-(cit60)/*[position()=1] publication-title: Bioconjugate Chem. doi: 10.1021/acs.bioconjchem.9b00755 contributor: fullname: Ziaei – volume: 501 start-page: 346 year: 2013 ident: D0BM00725K-(cit72)/*[position()=1] publication-title: Nature doi: 10.1038/nature12626 contributor: fullname: Junttila – volume: 84 start-page: 97 year: 2011 ident: D0BM00725K-(cit23)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2010.12.022 contributor: fullname: Meng – volume: 190 start-page: 210 year: 2014 ident: D0BM00725K-(cit25)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2014.04.014 contributor: fullname: Santoro – volume: 29 start-page: 3721 year: 2013 ident: D0BM00725K-(cit40)/*[position()=1] publication-title: Langmuir doi: 10.1021/la400268p contributor: fullname: Chen – volume: 9 start-page: 422 year: 2012 ident: D0BM00725K-(cit49)/*[position()=1] publication-title: Mol. Pharmaceutics doi: 10.1021/mp200522d contributor: fullname: Kaminskas – volume: 209 start-page: 120 year: 2015 ident: D0BM00725K-(cit38)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2015.04.032 contributor: fullname: Akash – volume: 75 start-page: 1 year: 2010 ident: D0BM00725K-(cit30)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2009.09.001 contributor: fullname: Sudesh – volume: 9 start-page: 421 year: 2018 ident: D0BM00725K-(cit57)/*[position()=1] publication-title: Front. Pharmacol. doi: 10.3389/fphar.2018.00421 contributor: fullname: Gou – volume: 368 start-page: 144 year: 2012 ident: D0BM00725K-(cit73)/*[position()=1] publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2011.11.024 contributor: fullname: Manju – volume: 5 start-page: 499 year: 2008 ident: D0BM00725K-(cit18)/*[position()=1] publication-title: Expert Opin. Drug Delivery doi: 10.1517/17425247.5.5.499 contributor: fullname: Wang – volume: 65 start-page: 157 year: 2013 ident: D0BM00725K-(cit3)/*[position()=1] publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.2012.01567.x contributor: fullname: Tacar – volume: 98 start-page: 8970 year: 1993 ident: D0BM00725K-(cit28)/*[position()=1] publication-title: J. Chem. Phys. doi: 10.1063/1.464456 contributor: fullname: Bohidar – volume: 1 start-page: 273 year: 2010 ident: D0BM00725K-(cit71)/*[position()=1] publication-title: Ther. Delivery doi: 10.4155/tde.10.24 contributor: fullname: Wang – volume: 113 start-page: 12928 year: 2009 ident: D0BM00725K-(cit11)/*[position()=1] publication-title: J. Phys. Chem. B doi: 10.1021/jp905781g contributor: fullname: Gou – volume: 14 start-page: 707 year: 2006 ident: D0BM00725K-(cit31)/*[position()=1] publication-title: J. Drug Targeting doi: 10.1080/10611860600935701 contributor: fullname: Lee – volume: 157 start-page: 168 year: 2012 ident: D0BM00725K-(cit19)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2011.07.031 contributor: fullname: Elzoghby – volume: 54 start-page: 191 year: 1998 ident: D0BM00725K-(cit27)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/S0168-3659(97)00247-2 contributor: fullname: Kurisawa – volume: 2 start-page: 1 year: 2017 ident: D0BM00725K-(cit5)/*[position()=1] publication-title: Oxid. Med. Cell. Longevity doi: 10.1155/2017/1521020 contributor: fullname: Cappetta – volume: 4 start-page: 707 year: 2007 ident: D0BM00725K-(cit15)/*[position()=1] publication-title: Mol. Pharm. doi: 10.1021/mp070058l contributor: fullname: Lu – volume: 34 start-page: 207 year: 2007 ident: D0BM00725K-(cit20)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2007.03.036 contributor: fullname: Dreis – volume: 66 start-page: 958 year: 1977 ident: D0BM00725K-(cit46)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600660714 contributor: fullname: Roy – volume: 10 start-page: 2007 year: 2015 ident: D0BM00725K-(cit55)/*[position()=1] publication-title: ACS Chem. Biol. doi: 10.1021/acschembio.5b00268 contributor: fullname: Jean – volume: 22 start-page: 763 year: 2001 ident: D0BM00725K-(cit62)/*[position()=1] publication-title: Biomaterials doi: 10.1016/S0142-9612(00)00236-2 contributor: fullname: Bigi – volume: 4 start-page: 6747 year: 2010 ident: D0BM00725K-(cit42)/*[position()=1] publication-title: ACS Nano doi: 10.1021/nn101617n contributor: fullname: Zhang – volume: 172 start-page: 1075 year: 2013 ident: D0BM00725K-(cit22)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2013.09.019 contributor: fullname: Elzoghby – volume: 99 start-page: 671 year: 1980 ident: D0BM00725K-(cit7)/*[position()=1] publication-title: Am. Heart J. doi: 10.1016/0002-8703(80)90743-7 contributor: fullname: Henderson – volume: 31 start-page: 7736 year: 1998 ident: D0BM00725K-(cit39)/*[position()=1] publication-title: Macromolecules doi: 10.1021/ma980982g contributor: fullname: Caragheorgheopol – volume: 5 start-page: 267 year: 1981 ident: D0BM00725K-(cit50)/*[position()=1] publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/BF00434396 contributor: fullname: Johansen – volume: 13 start-page: 1203 year: 2002 ident: D0BM00725K-(cit33)/*[position()=1] publication-title: J. Biomater. Sci. Polym. Ed. doi: 10.1163/156856202320892966 contributor: fullname: Ulubayram – volume: 1 start-page: 682 year: 2017 ident: D0BM00725K-(cit45)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2017.07.048 contributor: fullname: Das – volume: 49 start-page: 319 year: 1988 ident: D0BM00725K-(cit51)/*[position()=1] publication-title: J. Phys. France doi: 10.1051/jphys:01988004902031900 contributor: fullname: Djabourov – volume: 307 start-page: 93 year: 2006 ident: D0BM00725K-(cit29)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.10.010 contributor: fullname: Owens – volume: 98 start-page: 650 year: 1996 ident: D0BM00725K-(cit8)/*[position()=1] publication-title: J. Clin. Invest. doi: 10.1172/JCI118836 contributor: fullname: Minotti – volume: 21 start-page: 837 year: 2003 ident: D0BM00725K-(cit14)/*[position()=1] publication-title: Cancer Invest. doi: 10.1081/CNV-120025086 contributor: fullname: Chao – volume: 7 start-page: 21252 year: 2017 ident: D0BM00725K-(cit63)/*[position()=1] publication-title: RSC Adv. doi: 10.1039/C7RA01118K contributor: fullname: Yeh – volume: 6 start-page: 246 year: 2009 ident: D0BM00725K-(cit10)/*[position()=1] publication-title: Mol. Pharm. doi: 10.1021/mp8001528 contributor: fullname: Bayoumi – volume: 4 start-page: 3939 year: 2018 ident: D0BM00725K-(cit17)/*[position()=1] publication-title: ACS Biomater. Sci. Eng. doi: 10.1021/acsbiomaterials.8b01098 contributor: fullname: Jain – volume: 105 start-page: 460 year: 2016 ident: D0BM00725K-(cit35)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2015.11.015 contributor: fullname: Turecek – volume: 19 start-page: 1945 year: 2014 ident: D0BM00725K-(cit34)/*[position()=1] publication-title: Drug Discovery doi: 10.1016/j.drudis.2014.08.015 contributor: fullname: Verhoef – volume: 15 start-page: 1154 year: 1923 ident: D0BM00725K-(cit21)/*[position()=1] publication-title: Ind. Eng. Chem. doi: 10.1021/ie50167a018 contributor: fullname: Bogue – volume: 43 start-page: 211 year: 2001 ident: D0BM00725K-(cit75)/*[position()=1] publication-title: Pharmacol. Res. doi: 10.1006/phrs.2000.0769 contributor: fullname: Saad – volume: 1845 start-page: 84 year: 2014 ident: D0BM00725K-(cit4)/*[position()=1] publication-title: Biochim. Biophys. Acta contributor: fullname: Yang – volume: 1 start-page: 273 year: 2010 ident: D0BM00725K-(cit56)/*[position()=1] publication-title: Ther. Delivery doi: 10.4155/tde.10.24 contributor: fullname: Wang – volume: 27 start-page: 2225 year: 2016 ident: D0BM00725K-(cit68)/*[position()=1] publication-title: Bioconjugate Chem. doi: 10.1021/acs.bioconjchem.6b00437 contributor: fullname: Nakamura – volume: 20 start-page: 2780 year: 2010 ident: D0BM00725K-(cit70)/*[position()=1] publication-title: J. Mater. Chem. doi: 10.1039/b921735e contributor: fullname: Rio-Echevarria – volume: 567 start-page: 86 year: 2019 ident: D0BM00725K-(cit47)/*[position()=1] publication-title: Colloids Surf., A doi: 10.1016/j.colsurfa.2019.01.043 contributor: fullname: Das – volume: 85950 start-page: 1 year: 2013 ident: D0BM00725K-(cit67)/*[position()=1] publication-title: Proc. SPIE contributor: fullname: Khan – volume: 30 start-page: 1492 year: 2009 ident: D0BM00725K-(cit44)/*[position()=1] publication-title: Macromol. Rapid Commun. doi: 10.1002/marc.200900163 contributor: fullname: Wu – volume: 13 start-page: 124 year: 1996 ident: D0BM00725K-(cit76)/*[position()=1] publication-title: Pharm. Res. doi: 10.1023/A:1016097805003 contributor: fullname: Lefebvre – volume: 8 start-page: 22900 year: 2016 ident: D0BM00725K-(cit53)/*[position()=1] publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.6b07583 contributor: fullname: Suarasan – volume: 21 start-page: 797 year: 2010 ident: D0BM00725K-(cit13)/*[position()=1] publication-title: Bioconjugate Chem. doi: 10.1021/bc100070g contributor: fullname: Maeda – volume: 5 start-page: 202 year: 2004 ident: D0BM00725K-(cit32)/*[position()=1] publication-title: Biomacromolecules doi: 10.1021/bm0343139 contributor: fullname: Kushibiki – volume: 9 start-page: 519 year: 2018 ident: D0BM00725K-(cit1)/*[position()=1] publication-title: J. Nanomed. Nanotechnol. doi: 10.4172/2157-7439.1000519 contributor: fullname: Zhao – volume: 161 start-page: 38 year: 2012 ident: D0BM00725K-(cit16)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2012.04.036 contributor: fullname: Elzoghby – volume: 5 start-page: 3291 year: 2014 ident: D0BM00725K-(cit37)/*[position()=1] publication-title: Polym. Chem. doi: 10.1039/C4PY00039K contributor: fullname: Pitto-Barry – volume: 76 start-page: 48 year: 2010 ident: D0BM00725K-(cit26)/*[position()=1] publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2010.05.008 contributor: fullname: Curcio – volume: 5 start-page: 4131 year: 2011 ident: D0BM00725K-(cit12)/*[position()=1] publication-title: ACS Nano doi: 10.1021/nn200809t contributor: fullname: Meng – volume: 1 start-page: 1458 year: 2006 ident: D0BM00725K-(cit48)/*[position()=1] publication-title: Nat. Protoc. doi: 10.1038/nprot.2006.238 contributor: fullname: Riccardi – volume: 42 start-page: 71 year: 2019 ident: D0BM00725K-(cit65)/*[position()=1] publication-title: Bull. Mater. Sci. doi: 10.1007/s12034-019-1745-0 contributor: fullname: Dang – volume: 21 start-page: 440 year: 2011 ident: D0BM00725K-(cit2)/*[position()=1] publication-title: Pharmacogenet. Genomics doi: 10.1097/FPC.0b013e32833ffb56 contributor: fullname: Thorn – volume: 30 start-page: 1604 year: 2019 ident: D0BM00725K-(cit36)/*[position()=1] publication-title: Bioconjugate Chem. doi: 10.1021/acs.bioconjchem.9b00236 contributor: fullname: Hou – volume: 55 start-page: 2761 year: 1985 ident: D0BM00725K-(cit6)/*[position()=1] publication-title: Cancer doi: 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P contributor: fullname: Aman – volume: 1 start-page: 400 year: 2015 ident: D0BM00725K-(cit64)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2015.08.002 contributor: fullname: Tatini – volume: 14 start-page: 823 year: 1993 ident: D0BM00725K-(cit69)/*[position()=1] publication-title: Biomaterials doi: 10.1016/0142-9612(93)90004-L contributor: fullname: Tan – volume: 120 start-page: 2968 year: 2016 ident: D0BM00725K-(cit41)/*[position()=1] publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.6b00759 contributor: fullname: Mondal |
SSID | ssj0000779061 |
Score | 2.3356216 |
Snippet | The preparation of a water dispersible and pH responsive gelatin-F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that... The preparation of a water dispersible and pH responsive gelatin–F127 nanocomposite using a thermal relaxation approach is reported. The results indicated that... |
SourceID | proquest crossref pubmed rsc |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4251 |
SubjectTerms | Blood circulation Body weight Doxorubicin Drug Carriers Drug delivery systems Gelatin Hydrogen-Ion Concentration Nanocomposites Nanoparticles Organs Physical properties Poloxamer Poloxamers Room temperature Saline solutions Side effects Surface charge Sustained release Temperature Thermal relaxation Toxicity |
Title | Preparation of a size selective nanocomposite through temperature assisted co-assembly of gelatin and pluronic F127 for passive targeting of doxorubicin |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32583820 https://www.proquest.com/docview/2427526975/abstract/ https://search.proquest.com/docview/2417404063 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWVkLlgHi1pBRkBLdVIHESZ3PcQkt5FCGxlXqL_Apa0U1W-xCoJ34GP5cZO68ViwTkEEV24kj5vtifPeMZQp7LURwrFgg_kpjCzAjuy1jHfqGECJXKVGYtuucf-dlF_O4yuRwMfvS8ltYr-UJdb91X8j-oQhngirtk_wHZtlEogGvAF86AMJz_CuNPC-NCdzvRJ4bL6bUZLm1qG_QIKkVZoc84OmaZNiUPRqOqQykPQTojzri1zYdrM5NX1uT-xfrIOUfl-dXa5ck5DVlq3RLn-Bi079zIa79pXX2vFmuJlvoNS_G0AlHsvsawHm-75XG3ziNmoGS7pYHP0KJd7TmGSbYYvsEtarqzOZXfnFP4eDZd9RctmHOZcwOrsZ0bwwgR8ciFK2164lGfcEmvW4WOJdza3wcRhkvVgZxhCPTka_8mwGo-s8hHDI3DLOjGvNYTsam6QXZZmiUwfd8dn0zefmjX6QIMyMjDJrJtlL3s3rZHbjbPb8qa3-YqoFwWTUYZq1wmd8jtespBx44_d8nAlPfIrV4gyvvkZ49JtCqooMgk2jKJbjCJ1kyiPSbRhkm0xyRsqmYSBSbRhkkUmUSBSbRmEm2ZhI_0mPSAXJyeTF6d-XXODl9FPFr5BYs4KiBts9npgBvQmwWPw8CwTPKg0JnUMRcyUSzkaZpIpVShuNJSgtKV0T7ZKavSPCSUaQMFWVZormIm4ACxFcUjGSeFMOnII8-aT57PXWiW3LpURFn-Ojg-txi998hRg0Ze_7rLHHRpmjCepYlHnrbV0LGitUyUplrjPTBZhyGORx45cCi2r2lQ98g-wNoWd8zwyOH2inyui8M_tveI7HV_yxHZWS3W5jGI3pV8UvPyF2sptKY |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Royal Society of Chemistry |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preparation+of+a+size+selective+nanocomposite+through+temperature+assisted+co-assembly+of+gelatin+and+pluronic+F127+for+passive+targeting+of+doxorubicin&rft.jtitle=Biomaterials+science&rft.au=Das%2C+Ram+Pada&rft.au=Singh%2C+Beena+Gobind&rft.au=Kunwar%2C+Amit&rft.date=2020-08-07&rft.eissn=2047-4849&rft.volume=8&rft.issue=15&rft.spage=4251&rft_id=info:doi/10.1039%2Fd0bm00725k&rft_id=info%3Apmid%2F32583820&rft.externalDocID=32583820 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-4830&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-4830&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-4830&client=summon |